FDA Class II · Drug · September 2, 2026
Acthar Gel (repository corticotropin injection) recall — Mallinckrodt Hospital Products Inc.
Presence of particulate matter: glass and stopper piece
Official ID D-0803-2026 · Official record ↗
Mallinckrodt Hospital Products recalls
Recall found. Mallinckrodt Hospital Products is named in FDA Class II recall D-0803-2026 covering Acthar Gel (repository corticotropin injection). Hazard: Presence of particulate matter: glass and stopper piece Identifying details: Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027. Status: Ongoing.
Models with recalls
All Mallinckrodt Hospital Products recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked October 22, 2026 at 12:00 PM UTC.